🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DA-EPOCH-R

Found 0 matching trials

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

PHASE2

This phase II trial evaluates whether loncastuximab tesirine and rituximab ...

Status

Recruiting

Location

University of California Davis Comprehensive Cancer Center

Start Date

2023-05-24

Trial ID

NCT05600686

Treatments Being Tested

Cyclophosphamide Doxorubicin Etoposide Loncastuximab Tesirine Prednisone Rituximab Vincristine

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

PHASE3

This phase III trial compares the effects of nivolumab with chemo-immunothe...

Status

Active Not Recruiting

Location

Children's Hospital of Alabama

Start Date

2021-10-05

Trial ID

NCT04759586

Treatments Being Tested

Biospecimen Collection Bone Marrow Aspiration Bone Marrow Biopsy Computed Tomography Cyclophosphamide Doxorubicin Hydrochloride Echocardiography Test Etoposide Phosphate Filgrastim Lumbar Puncture Nivolumab Pegfilgrastim Positron Emission Tomography Prednisolone Prednisone Radiation Therapy Rituximab Rituximab and Hyaluronidase Human Vincristine Sulfate

Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas

PHASE1

This partially randomized phase I/II trial studies the side effects and the...

Status

Completed

Location

Jackson Hospital and Clinic

Start Date

2010-10-06

Trial ID

NCT01193842

Treatments Being Tested

Cyclophosphamide Doxorubicin Hydrochloride Etoposide Laboratory Biomarker Analysis Pharmacological Study Prednisone Rituximab Vincristine Sulfate Vorinostat

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

PHASE1

Background: Burkitt Lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL...

Status

Terminated

Location

National Institutes of Health Clinical Center

Start Date

2022-03-24

Trial ID

NCT04933617

Treatments Being Tested

Rituximab Etoposide Copanlisib Cyclophosphamide Doxorubicin Vincristine Prednisone ECHO EKG MRI Brain 18F-FDG - PET CT Scan Bone Marrow Aspiration Bone Marrow Biopsy Lumbar Puncture (LP)

DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma

PHASE2

Newly diagnosed histologically confirmed c-myc+ de novo DLBCL. Metformin 50...

Status

Terminated

Location

Rush University Medical Center

Start Date

2016-02

Trial ID

NCT02815397

Treatments Being Tested

Metformin

Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

PHASE1

This is a phase I, open label, single-arm, multi-center, dose-finding study...

Status

Completed

Location

Massachusetts General Hospital Cancer Center

Start Date

2017-02-06

Trial ID

NCT03036904

Treatments Being Tested

Venetoclax Rituximab Etoposide Vincristine Sulfate Cyclophosphamide Prednisone Doxorubicin Hydrochloride

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

PHASE1

This phase I/II trial studies the side effects and best dose of lenalidomid...

Status

Completed

Location

Rush University Medical Center

Start Date

2014-07-29

Trial ID

NCT02213913

Treatments Being Tested

lenalidomide etoposide prednisone vincristine sulfate doxorubicin hydrochloride cyclophosphamide rituximab quality-of-life assessment laboratory biomarker analysis

R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL

PHASE3

Patients initially are randomized into 2 arms: Arm I: R-DA-EPOCH; Arm II: ...

Status

Unknown

Location

Fujian Medical University Union Hospital

Start Date

2017-07-10

Trial ID

NCT03213977

Treatments Being Tested

R-DA-EPOCH R-CEOP90

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

PHASE3

Purpose: to evaluate an efficacy of chemotherapy regimens R-DA-EPOCH-21 and...

Status

Unknown

Location

National Research Center for Hematology

Start Date

2018-03-15

Trial ID

NCT03479918

Treatments Being Tested

R-DA-EPOCH-21 R-BL-M-04 R-DA-EPOCH-21 + auto-SCT R-BL-M-04 + auto-SCT

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

PHASE2

This study is testing whether stratification of the patients according to b...

Status

Unknown

Location

Aarhus University Hospital

Start Date

2017-08-04

Trial ID

NCT03293173

Treatments Being Tested

R-CHOEP DA-EPOCH-R

Previous Next